32 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
; reputational harm; diminished profits; and the curtailment or restructuring of our operations. If any of the physicians or other providers or Table of Contents … , industrial espionage attacks, or insider threat attacks, which could result in financial, legal, business, or reputational harm. Our employees, clinical
ARS
riows75tasasgsjtsm9n
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
q2oyxnq
11 Aug 22
Definitive proxy
4:04pm
10-K
EX-10.39
ym3cy 75til
21 Mar 22
Annual report
4:19pm
10-K
EX-10.42
b2g vqe8q8hec
21 Mar 22
Annual report
4:19pm
10-K
1324fw3d2ioulzg 3f5d
21 Mar 22
Annual report
4:19pm
8-K
EX-10.2
95vli18wmua5
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.3
ry5mkq0 qbw4ynzt
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.4
0smt1s
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.1
of8npe
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
424B4
t29spt3m czt1c4a2ou
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
EX-10.34
86la6k
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.38
ucv136e
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.40
g7kb3w
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
gkjlqrgeh
19 Jul 21
IPO registration (amended)
6:09am